Section Arrow
Quote
ERNA.NASDAQ
- Ernexa Therapeutics Inc
Quotes are at least 15-min delayed:2025/07/20 16:59 EDT
Regular Hours
Last
 1.98
-0.06 (-2.94%)
Day High 
2.09 
Prev. Close
2.04 
1-M High
2.65 
Volume 
64.71K 
Bid
1.95
Ask
2.04
Day Low
1.9509 
Open
2.09 
1-M Low
1.75 
Market Cap 
15.02M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.95 
20-SMA 2.01 
50-SMA 2.64 
52-W High 35.1015 
52-W Low 1.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-32.70/-10.80
Enterprise Value
15.49M
Balance Sheet
Book Value Per Share
-0.81
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
68.00K
Operating Revenue Per Share
1.95
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
NCNANuCana plc0.0477+0.0009+1.92%-- 
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Quotes are at least 15-min delayed：2025/07/20 16:59 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.